USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Horteve Breeding BV

USPTO PatentsView assignee record - 46 granted patents across 0 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength.

RSS updates for this company

The verdict

According to USPTO PatentsView, Horteve ranks #7,147 of 49,997 tracked US assignees by granted-patent volume, with 46 patents across 0 technology areas.

#7,147
of 49,997 US assignees by volume
4th percentile
by Innovation Score (16.9/100)
1.0
avg claims per patent
+0%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R7147 · Foreign Corporation #7,147 · 46 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-UNK · INNOV-LOW · CLAIMS-SPARSE · TYPE-FRNCORP · VEL-FLAT · BOOK-RICH

  • GRANTS-SMALL 46 grants
  • UPPER-Q #7,147/49,997
  • PHOTO-FINISH Five Prime Therapeut…
  • CPC-UNK CPC blank
  • INNOV-LOW 16.9/100
  • CLAIMS-SPARSE 1.0 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-FLAT +0% vel
  • BOOK-RICH 9/10 fields

Nearest grant-volume peer: Five Prime Therapeutics, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Horteve’s 16.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Horteve

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Horteve's Innovation Score is 16.9/100 (4th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Horteve?

Each dot is one of Horteve’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Horteve’s own 1.0 claims/patent is at or below the 11.4 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Horteve vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 45.946.046.04646.046.046.1 010203040 Granted patents (volume) Avg claims / patent Five Prime Therapeutics, Inc. - 46, 25.02Five Prime Therap…Foro Energy, Inc. - 46, 36.09Foro EnergyGamesa Innovation & Technology, S. L. - 46, 11.39Gamesa Innovation…GE Jenbacher GmbH Co OG - 46, 14.72GE Jenbacher OGHarro Hoefliger Verpackungsmaschinen GmbH - 46, 10.54Harro Hoefliger V…Hay ApS - 46, 1Hay ApsHisense Laser Display Co., Ltd - 46, 18.33Hisense Laser Dis…I-tek Metal MFG. Co., Ltd. - 46, 7.65I-tek Metal MFGHorteve Breeding BV - 46, 1Horteve Breeding…
Horteve vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Horteve's grants concentrate

Horteve Breeding BV is a focused PatentsView assignee: 0 CPC subclasses . Peak complete grant year is 2020 (11 grants) versus a trough of 1 in 2015. By volume, Horteve sits between Five Prime Therapeutics, Inc. and I-tek Metal MFG. Co., Ltd..

Horteve's three-year grant acceleration

From 2019–2021 to 2022–2024, Horteve Breeding BV moved from 22 to 10 grants (0.46x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Who files at Horteve's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Horteve holds 46 patents at rank #7,144, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Horteve

By rank, the assignees closest to #7,144 in granted patent volume.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Horteve, neither rank-band nor same-CPC leaders (those blocks stay above).

Horteve's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

17 4th percentile higher than 4% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

051015 20152016201720182019202020212022202320242025 2
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Horteve Breeding BV patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 1 2.2%
2016 1 2.2%
2017 4 8.7%
2018 6 13.0%
2019 10 21.7%
2020 11 23.9%
2021 1 2.2%
2022 3 6.5%
2023 4 8.7%
2024 3 6.5%
2025partial year 2 4.3%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Horteve Breeding BV's patent record in context - here's where to go next.

  • Ranked #7,147 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Horteve Breeding BV against Five Prime Therapeutics, Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 16.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.